The American Cancer Society in Central Indiana has set a goal to enroll 1,000 Central Indiana residents in Cancer Prevention Study-3, a groundbreaking nationwide prevention study.
More than 600 individuals have booked an appointment to participate in the upcoming enrollment.
Organizers hope to engage at least 400 more individuals in the local initiative that has the potential to change the face of cancer for future generations.
Cancer Prevention Study-3 (CPS-3) is an American Cancer Society research study that will help researchers better understand the lifestyle, genetic, behavioral and environmental factors that cause or prevent cancer.
Appointments to enroll in the study can be made by going to www.cps3indy.com or by calling 1-888-604-5888.
The following locations will serve as enrollment sites, open to the locations’ employees, constituents and to the general public:
- Roche Diagnostics: Oct. 4 – 5, 9115 Hague Road, Indianapolis, IN 46250 and 10300 Kincaid Dr., Fishers, IN 46038.
- Eli Lilly and Co.: Oct. 6, Riverside Park, 2420 E. Riverside Dr., Indianapolis, IN 46208.
- Franciscan St. Francis Health: Oct. 7-8, 8111 S. Emerson Ave., Indianapolis, IN 46237.
- St. Vincent Cancer Care: Oct. 6-8, 8301 N. Harcourt Road, Indianapolis, IN 46260.
- Anthem Blue Cross/Blue Shield: Oct. 7, 220 Virginia Ave., Indianapolis, IN 46204.
- Indiana University Health: Oct. 4-5, West Hospital – 1111 N. Ronald Reagan Parkway, Avon, IN 46123; Oct. 6-7 Indiana University Melvin and Bren Simon Cancer Center – 535 Barnhill Dr., Indianapolis, IN 46202.
- East 91st Street Christian Church: Oct. 7-8, 6049 E. 91st St., Indianapolis, IN 46250.
“Many individuals diagnosed with cancer struggle to answer the question, ‘What caused my cancer?’ In many cases, we don’t know the answer,” said Alpa V. Patel, Ph.D., principal investigator of CPS-3. “CPS-3 will help us better understand what factors cause cancer, and once we know that, we can be better equipped to prevent cancer.”
Dr. Patel added, “Our previous cancer prevention studies have been instrumental in helping us identify some of the major factors that can affect cancer risk. CPS-3 holds the best hope of identifying new and emerging cancer risks, and we can only do this if members of the community are willing to become involved.”
Men and women who are willing to commit to the long-term study must be between the ages of 30 and 65 and never have been diagnosed with cancer. To enroll in the study, individuals provide a waist measurement, give a small blood sample and complete a comprehensive survey.
Over the course of the study, participants will be asked to fill out follow-up surveys every few years. The study will enroll a diverse population of 300,000 people across the United States.
For more information or to learn how to become involved with CPS-3, visit www.cps3indy.com, email cps3@cancer.org, or call toll-free 1-888-604-5888.
